A detailed history of Bank Of America Corp transactions in Nevro Corp stock. As of the latest transaction made, Bank Of America Corp holds 440,428 shares of NVRO stock, worth $2.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
440,428
Previous 334,647 31.61%
Holding current value
$2.19 Million
Previous $4.83 Million 23.26%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.96 - $13.59 $842,016 - $1.44 Million
105,781 Added 31.61%
440,428 $3.71 Million
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $742,979 - $1.14 Million
54,792 Added 19.58%
334,647 $4.83 Million
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $1.56 Million - $2.45 Million
109,664 Added 64.44%
279,855 $6.02 Million
Q2 2023

Aug 14, 2023

SELL
$22.62 - $39.32 $399,220 - $693,958
-17,649 Reduced 9.4%
170,191 $4.33 Million
Q1 2023

May 12, 2023

SELL
$30.17 - $41.11 $5.99 Million - $8.16 Million
-198,429 Reduced 51.37%
187,840 $6.79 Million
Q4 2022

Feb 10, 2023

BUY
$36.43 - $49.4 $9.25 Million - $12.5 Million
253,787 Added 191.56%
386,269 $15.3 Million
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $2.24 Million - $2.92 Million
-55,013 Reduced 29.34%
132,482 $6.17 Million
Q2 2022

Aug 12, 2022

BUY
$40.85 - $77.67 $759,033 - $1.44 Million
18,581 Added 11.0%
187,495 $8.22 Million
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $2.75 Million - $4.23 Million
45,933 Added 37.35%
168,914 $12.2 Million
Q4 2021

Feb 08, 2022

SELL
$81.07 - $121.29 $2.34 Million - $3.5 Million
-28,862 Reduced 19.01%
122,981 $9.97 Million
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $1.56 Million - $2.54 Million
-15,290 Reduced 9.15%
151,843 $17.7 Million
Q2 2021

Sep 13, 2021

BUY
$141.6 - $179.06 $23.7 Million - $29.9 Million
167,133 New
167,133 $27.7 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $176M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.